Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025
The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025.
An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.
The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.
The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.
The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.
The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
- By Product
- Vital organs support systems
- Artificial Heart
- Artificial Kidney
- Artificial Pancreas
- Artificial Urinary Bladder
- Artificial Lungs
- Artificial Liver
- Medical Bionics
- Bionic Eye
- Ear Bionics
- Cochlear Implants
- Bone Anchored Hearing Systems
- Auditory Brainstem Implants
- Orthopedic Bionics
- Upper limb
- Lower limb
- Bionic Knee
- Bionic Feet
- Exoskeleton
- Electrical Bone Growth Stimulators
- Non-Invasive Bone Growth Stimulators
- Invasive Bone Growth Stimulators
- Cardiac Bionics
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- Ventricular Assist Device
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BIVAD)
- Artificial Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Neural Bionics
- Internal Neurostimulators
- Deep Brain Stimulators (DBS)
- Sacral Nerve Stimulators (SNS)
- Vagus Nerve Stimulators (VNS)
- Spinal Cord Stimulators (SCS)
- Other Neurostimulators
- External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abiomed, Inc.
- Abbott Laboratories
- Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
- Baxter International Inc.
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Jarvik Heart, Inc.
- Medtronic Plc.
- ?ssur Americas, Inc.
- Second Sight Medical Products, Inc.
- SynCardia Systems LLC
- Getinge AB
- LivaNova PLC
- Fresenius Medical Care AG & Co. KGaA
- Heartware International Inc.
- BiVACOR
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3. Pricing Analysis
3.3.1. Pricing Analysis, By Region, 2018 & 2025
3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1. Case Study
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2. Restraints
3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process
3.9.3. Opportunities
3.9.3.1. Lucrative opportunities in emerging economies
CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Artificial Heart
4.3.2.1.1. Market size and forecast
4.3.2.2. Artificial Kidney
4.3.2.2.1. Market size and forecast
4.3.2.3. Artificial Pancreas
4.3.2.3.1. Market size and forecast
4.3.2.4. Artificial Urinary Bladder
4.3.2.4.1. Market size and forecast
4.3.2.5. Artificial Lungs
4.3.2.5.1. Market size and forecast
4.3.2.6. Artificial Liver
4.3.2.6.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country
4.4. Medical Bionics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Bionic Eye
4.4.2.1.1. Market size and forecast
4.4.2.2. Ear Bionics
4.4.2.2.1. Market size and forecast, by type
4.4.2.2.1.1.1. Cochlear Implants
4.4.2.2.1.1.1.1 Market size and forecast
4.4.2.2.1.1.2. Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1. Market size and forecast
4.4.2.2.1.1.3. Auditory Brainstem Implants
4.4.2.2.1.1.3.1 Market size and forecast
4.4.2.3. Orthopedic Bionics
4.4.2.3.1. Market size and forecast, by type
4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1. Bionic Knee
4.4.2.3.1.1.4.1.1. Market size and forecast
4.4.2.3.1.1.4.2. Bionic Feet
4.4.2.3.1.1.4.2.1. Market size and forecast
4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1. Market size and forecast
4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1. Market size and forecast
4.4.2.4. Cardiac Bionics
4.4.2.4.1. Market size and forecast, by type
4.4.2.4.1.1.1. Pacemaker
4.4.2.4.1.1.1.1 Market size and forecast, by type
4.4.2.4.1.1.2. Implantable Pacemaker
4.4.2.4.1.1.2.1. Market size and forecast
4.4.2.4.1.1.3. External pacemaker
4.4.2.4.1.1.3.1 Market size and forecast
4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4. Market size and forecast, by type
4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1. Market size and forecast
4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1. Market size and forecast
4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1. Market size and forecast
4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1. Mechanical Heart Valves
4.4.2.4.1.1.6.1.1. Market size and forecast
4.4.2.4.1.1.6.2. Tissue Heart Valves
4.4.2.4.1.1.6.2.1. Market size and forecast
4.4.2.5. Neural Bionics
4.4.2.5.1. Market size and forecast, by type
4.4.2.5.1.1. Internal Neurostimulators
4.4.2.5.1.1.1. Market size and forecast, by type
4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1. Market size and forecast
4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1. Market size and forecast
4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1. Market size and forecast
4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1. Market size and forecast
4.4.2.5.1.1.1.5. Other Neurostimulators
4.4.2.5.1.1.1.5.1. Market size and forecast
4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country
CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1. Overview
5.2. Market size and forecast
5.3. Hospitals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Ambulatory surgical centers (ASCs)
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country
6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user
6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country
6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user
6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country
6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user
6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country
6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user
6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies
7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*
7.5. Product Mapping of Top 12 Player
CHAPTER 8: COMPANY PROFILES:
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Abbott Laboratories (St. Jude Medical)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Baxter International Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Cochlear Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Edwards Lifesciences Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Jarvik Heart, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. Medtronic Plc. (Covidien Ltd.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. ?ssur Americas, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Second Sight Medical Products, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3. Pricing Analysis
3.3.1. Pricing Analysis, By Region, 2018 & 2025
3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1. Case Study
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2. Restraints
3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process
3.9.3. Opportunities
3.9.3.1. Lucrative opportunities in emerging economies
CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Artificial Heart
4.3.2.1.1. Market size and forecast
4.3.2.2. Artificial Kidney
4.3.2.2.1. Market size and forecast
4.3.2.3. Artificial Pancreas
4.3.2.3.1. Market size and forecast
4.3.2.4. Artificial Urinary Bladder
4.3.2.4.1. Market size and forecast
4.3.2.5. Artificial Lungs
4.3.2.5.1. Market size and forecast
4.3.2.6. Artificial Liver
4.3.2.6.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country
4.4. Medical Bionics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Bionic Eye
4.4.2.1.1. Market size and forecast
4.4.2.2. Ear Bionics
4.4.2.2.1. Market size and forecast, by type
4.4.2.2.1.1.1. Cochlear Implants
4.4.2.2.1.1.1.1 Market size and forecast
4.4.2.2.1.1.2. Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1. Market size and forecast
4.4.2.2.1.1.3. Auditory Brainstem Implants
4.4.2.2.1.1.3.1 Market size and forecast
4.4.2.3. Orthopedic Bionics
4.4.2.3.1. Market size and forecast, by type
4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1. Bionic Knee
4.4.2.3.1.1.4.1.1. Market size and forecast
4.4.2.3.1.1.4.2. Bionic Feet
4.4.2.3.1.1.4.2.1. Market size and forecast
4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1. Market size and forecast
4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1. Market size and forecast
4.4.2.4. Cardiac Bionics
4.4.2.4.1. Market size and forecast, by type
4.4.2.4.1.1.1. Pacemaker
4.4.2.4.1.1.1.1 Market size and forecast, by type
4.4.2.4.1.1.2. Implantable Pacemaker
4.4.2.4.1.1.2.1. Market size and forecast
4.4.2.4.1.1.3. External pacemaker
4.4.2.4.1.1.3.1 Market size and forecast
4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4. Market size and forecast, by type
4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1. Market size and forecast
4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1. Market size and forecast
4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1. Market size and forecast
4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1. Mechanical Heart Valves
4.4.2.4.1.1.6.1.1. Market size and forecast
4.4.2.4.1.1.6.2. Tissue Heart Valves
4.4.2.4.1.1.6.2.1. Market size and forecast
4.4.2.5. Neural Bionics
4.4.2.5.1. Market size and forecast, by type
4.4.2.5.1.1. Internal Neurostimulators
4.4.2.5.1.1.1. Market size and forecast, by type
4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1. Market size and forecast
4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1. Market size and forecast
4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1. Market size and forecast
4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1. Market size and forecast
4.4.2.5.1.1.1.5. Other Neurostimulators
4.4.2.5.1.1.1.5.1. Market size and forecast
4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country
CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1. Overview
5.2. Market size and forecast
5.3. Hospitals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Ambulatory surgical centers (ASCs)
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country
6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user
6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country
6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user
6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country
6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user
6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country
6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user
6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies
7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*
7.5. Product Mapping of Top 12 Player
CHAPTER 8: COMPANY PROFILES:
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Abbott Laboratories (St. Jude Medical)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Baxter International Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Cochlear Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Edwards Lifesciences Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Jarvik Heart, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. Medtronic Plc. (Covidien Ltd.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. ?ssur Americas, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Second Sight Medical Products, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 02. VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 03. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR VITAL ORGANS SUPPORT SYSTEMS , BY REGION 2017–2025 ($MILLION)
TABLE 04. MEDICAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 05. EAR BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 06. ORTHOPEDIC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. LOWER LIMB MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 08. ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 09. CARDIAC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 10. PACEMAKER MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 12. ARTIFICIAL HEART VALVES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 13. NEURAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 14. INTERNAL NEUROSTIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 15. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR MEDICAL BIONICS, BY REGION 2017–2025 ($MILLION)
TABLE 16. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 17. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR HARDWARE, BY REGION 2017–2025($MILLION)
TABLE 18. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2017–2025($MILLION)
TABLE 19. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR OTHER END USERS, BY REGION, 2017–2025($MILLION)
TABLE 20. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 21. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 22. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 23. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 24. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 25. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 27. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 28. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 30. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 31. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 32. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 33. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 34. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 35. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 37. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 38. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 40. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 41. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 43. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 44. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 46. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 47. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 50. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 51. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 52. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 53. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 57. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 59. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 60. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 61. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 62. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 63. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 66. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 69. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 70. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 71. ABIOMED: COMPANY SNAPSHOT
TABLE 72. ABIOMED: PRODUCT PORTFOLIO
TABLE 73. ABBOTT: COMPANY SNAPSHOT
TABLE 74. ABBOTT: OPERATING SEGMENTS
TABLE 75. ABBOTT: PRODUCT PORTFOLIO
TABLE 76. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 77. ASAHI KASEI: OPERATING SEGMENTS
TABLE 78. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 79. BAXTER: COMPANY SNAPSHOT
TABLE 80. BAXTER: OPERATING SEGMENTS
TABLE 81. BAXTER: PRODUCT PORTFOLIO
TABLE 82. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 84. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 85. COCHLEAR: COMPANY SNAPSHOT
TABLE 86. COCHLEAR: OPERATING SEGMENTS
TABLE 87. COCHLEAR: PRODUCT PORTFOLIO
TABLE 88. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 89. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 90. JARVIK HEART: COMPANY SNAPSHOT
TABLE 91. JARVIK HEART: PRODUCT PORTFOLIO
TABLE 92. MEDTRONIC: COMPANY SNAPSHOT
TABLE 93. MEDTRONIC: OPERATING SEGMENTS
TABLE 94. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 95. ?SSUR: COMPANY SNAPSHOT
TABLE 96. ?SSUR: OPERATING SEGMENTS
TABLE 97. ?SSUR: PRODUCT PORTFOLIO
TABLE 98. SECOND SIGHT: COMPANY SNAPSHOT
TABLE 99. SECOND SIGHT: PRODUCT PORTFOLIO
TABLE 100. SYNCARDIA: COMPANY SNAPSHOT
TABLE 101. SYNCARDIA: PRODUCT PORTFOLIO
TABLE 01. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 02. VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 03. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR VITAL ORGANS SUPPORT SYSTEMS , BY REGION 2017–2025 ($MILLION)
TABLE 04. MEDICAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 05. EAR BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 06. ORTHOPEDIC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. LOWER LIMB MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 08. ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 09. CARDIAC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 10. PACEMAKER MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 12. ARTIFICIAL HEART VALVES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 13. NEURAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 14. INTERNAL NEUROSTIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 15. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR MEDICAL BIONICS, BY REGION 2017–2025 ($MILLION)
TABLE 16. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 17. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR HARDWARE, BY REGION 2017–2025($MILLION)
TABLE 18. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2017–2025($MILLION)
TABLE 19. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR OTHER END USERS, BY REGION, 2017–2025($MILLION)
TABLE 20. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 21. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 22. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 23. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 24. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 25. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 27. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 28. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 30. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 31. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 32. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 33. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 34. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 35. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 37. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 38. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 40. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 41. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 43. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 44. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 46. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 47. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 50. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 51. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 52. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 53. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 57. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 59. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 60. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 61. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 62. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 63. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 66. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 69. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 70. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 71. ABIOMED: COMPANY SNAPSHOT
TABLE 72. ABIOMED: PRODUCT PORTFOLIO
TABLE 73. ABBOTT: COMPANY SNAPSHOT
TABLE 74. ABBOTT: OPERATING SEGMENTS
TABLE 75. ABBOTT: PRODUCT PORTFOLIO
TABLE 76. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 77. ASAHI KASEI: OPERATING SEGMENTS
TABLE 78. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 79. BAXTER: COMPANY SNAPSHOT
TABLE 80. BAXTER: OPERATING SEGMENTS
TABLE 81. BAXTER: PRODUCT PORTFOLIO
TABLE 82. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 84. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 85. COCHLEAR: COMPANY SNAPSHOT
TABLE 86. COCHLEAR: OPERATING SEGMENTS
TABLE 87. COCHLEAR: PRODUCT PORTFOLIO
TABLE 88. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 89. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 90. JARVIK HEART: COMPANY SNAPSHOT
TABLE 91. JARVIK HEART: PRODUCT PORTFOLIO
TABLE 92. MEDTRONIC: COMPANY SNAPSHOT
TABLE 93. MEDTRONIC: OPERATING SEGMENTS
TABLE 94. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 95. ?SSUR: COMPANY SNAPSHOT
TABLE 96. ?SSUR: OPERATING SEGMENTS
TABLE 97. ?SSUR: PRODUCT PORTFOLIO
TABLE 98. SECOND SIGHT: COMPANY SNAPSHOT
TABLE 99. SECOND SIGHT: PRODUCT PORTFOLIO
TABLE 100. SYNCARDIA: COMPANY SNAPSHOT
TABLE 101. SYNCARDIA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. TOP INVESTMENT POCKETS
FIGURE 05. VALUE CHAIN ANALYSIS
FIGURE 06. CLINICAL TRIALS IN MEDICAL BIONICS MARKET, BY REGION
FIGURE 07. CLINICAL TRIALS FOR MEDICAL DEVICES (%)
FIGURE 08. DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2018
FIGURE 09. ARTIFICIAL HEART MARKET, 2017–2025 ($MILLION)
FIGURE 10. ARTIFICIAL KIDNEY MARKET, 2017–2025 ($MILLION)
FIGURE 11. ARTIFICIAL PANCREAS MARKET, 2017–2025 ($MILLION)
FIGURE 12. ARTIFICIAL URINARY BLADDER MARKET, 2017–2025 ($MILLION)
FIGURE 13. ARTIFICIAL LUNGS MARKET, 2017–2025 ($MILLION)
FIGURE 14. ARTIFICIAL LIVER MARKET, 2017–2025 ($MILLION)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. BIONIC EYE MARKET, 2017–2025 ($MILLION)
FIGURE 17. COCHLEAR IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 18. BONE ANCHORED HEARING SYSTEMS MARKET, 2017–2025 ($MILLION)
FIGURE 19. AUDITORY BRAINSTEM IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 20. UPPER LIMB MARKET, 2017–2025 ($MILLION)
FIGURE 21. BIONIC KNEE MARKET, 2017–2025 ($MILLION)
FIGURE 22. BIONIC FEET MARKET, 2017–2025 ($MILLION)
FIGURE 23. EXOSKELETON MARKET, 2017–2025 ($MILLION)
FIGURE 24. INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 25. NON-INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 26. IMPLANTABLE PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 27. EXTERNAL PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 28. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 29. RIGHT VENTRICULAR ASSIST DEVICE (RVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 30. BIVENTRICULAR ASSIST DEVICE (BIVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 31. MECHANICAL HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 32. TISSUE HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 33. DEEP BRAIN STIMULATORS (DBS) MARKET, 2017–2025 ($MILLION)
FIGURE 34. SACRAL NERVE STIMULATORS (SNS) MARKET, 2017–2025 ($MILLION)
FIGURE 35. VAGUS NERVE STIMULATORS (VNS) MARKET, 2017–2025 ($MILLION)
FIGURE 36. SPINAL CORD STIMULATORS (SCS) MARKET, 2017–2025 ($MILLION)
FIGURE 37. OTHER NEUROSTIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 38. EXTERNAL NEUROMODULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 39. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 40. COMPARATIVE SHARE ANALYSIS OF NON-COATED VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 41. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2017 & 2025 (%)
FIGURE 42. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 43. MARKET SHARE ANALYSIS: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, 2018 (%)
FIGURE 44. PRODUCT MAPPING OF TOP 12 PLAYERS
FIGURE 45. ABIOMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 46. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. ASAHI KASEI: NET SALES, 2015–2017 ($MILLION)
FIGURE 50. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 52. BAXTER: NET SALES, 2015–2017 ($MILLION)
FIGURE 53. BAXTER: REV
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. TOP INVESTMENT POCKETS
FIGURE 05. VALUE CHAIN ANALYSIS
FIGURE 06. CLINICAL TRIALS IN MEDICAL BIONICS MARKET, BY REGION
FIGURE 07. CLINICAL TRIALS FOR MEDICAL DEVICES (%)
FIGURE 08. DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2018
FIGURE 09. ARTIFICIAL HEART MARKET, 2017–2025 ($MILLION)
FIGURE 10. ARTIFICIAL KIDNEY MARKET, 2017–2025 ($MILLION)
FIGURE 11. ARTIFICIAL PANCREAS MARKET, 2017–2025 ($MILLION)
FIGURE 12. ARTIFICIAL URINARY BLADDER MARKET, 2017–2025 ($MILLION)
FIGURE 13. ARTIFICIAL LUNGS MARKET, 2017–2025 ($MILLION)
FIGURE 14. ARTIFICIAL LIVER MARKET, 2017–2025 ($MILLION)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. BIONIC EYE MARKET, 2017–2025 ($MILLION)
FIGURE 17. COCHLEAR IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 18. BONE ANCHORED HEARING SYSTEMS MARKET, 2017–2025 ($MILLION)
FIGURE 19. AUDITORY BRAINSTEM IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 20. UPPER LIMB MARKET, 2017–2025 ($MILLION)
FIGURE 21. BIONIC KNEE MARKET, 2017–2025 ($MILLION)
FIGURE 22. BIONIC FEET MARKET, 2017–2025 ($MILLION)
FIGURE 23. EXOSKELETON MARKET, 2017–2025 ($MILLION)
FIGURE 24. INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 25. NON-INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 26. IMPLANTABLE PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 27. EXTERNAL PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 28. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 29. RIGHT VENTRICULAR ASSIST DEVICE (RVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 30. BIVENTRICULAR ASSIST DEVICE (BIVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 31. MECHANICAL HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 32. TISSUE HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 33. DEEP BRAIN STIMULATORS (DBS) MARKET, 2017–2025 ($MILLION)
FIGURE 34. SACRAL NERVE STIMULATORS (SNS) MARKET, 2017–2025 ($MILLION)
FIGURE 35. VAGUS NERVE STIMULATORS (VNS) MARKET, 2017–2025 ($MILLION)
FIGURE 36. SPINAL CORD STIMULATORS (SCS) MARKET, 2017–2025 ($MILLION)
FIGURE 37. OTHER NEUROSTIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 38. EXTERNAL NEUROMODULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 39. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 40. COMPARATIVE SHARE ANALYSIS OF NON-COATED VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 41. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2017 & 2025 (%)
FIGURE 42. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 43. MARKET SHARE ANALYSIS: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, 2018 (%)
FIGURE 44. PRODUCT MAPPING OF TOP 12 PLAYERS
FIGURE 45. ABIOMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 46. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. ASAHI KASEI: NET SALES, 2015–2017 ($MILLION)
FIGURE 50. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 52. BAXTER: NET SALES, 2015–2017 ($MILLION)
FIGURE 53. BAXTER: REV
